Michael Barbella, Managing Editor05.03.24
New Leaf Venture Partners, Arboretum Ventures, Genesys Capital, and iGan Partners have funneled $20 million in Series C financing to wearable medical ultrasound developer Flosonics Medical. The company plans to use the money to drive market adoption of FloPatch, a first-in-class wearable Doppler ultrasound for hemodynamic assessments.
Vijay Lathi, an experienced medtech investor with a focus on data convergence and guiding growth-stage companies, is joining Flosonics Medical’s board of directors. “We are thrilled to have New Leaf Venture Partners lead our Series C round and welcome Vijay Lathi to our board,” Flosonics Medical CEO Joe Eibl said. “This investment not only validates our past successes but also enables us to accelerate our plans for expansion and innovation. We are committed to leveraging this funding to further enhance the standard of care for critically ill patients with FloPatch and expand our reach into new markets.”
Flosonics Medical plans to use the Series C investment to accelerate commercial growth, expand indications for use, and continue evidence generation. The company aims to address the growing demand for wearable AI-assisted sensors to improve patient management inside and outside the hospital.
“Our investment into Flosonics is driven by the clear and significant impact their technology will have on patients in critical situations, and the quality of the team behind it. Flosonics Medical stands at the forefront of wearable ultrasound, and we look forward to contributing to their continued success,” Lathi stated on behalf of New Leaf Venture Partners.
Flosonics Medical is a Canadian medical device company engaged in the research and development of ultrasound technology. Founded in 2015, the company aims to improve patient care and the practice of medicine through technology-enabled solutions and clinical research.
New Leaf Venture Partners is a healthcare technology venture investing firm that supports both healthcare-related information technology companies and public and private biopharmaceutical companies. New Leaf currently manages more than $500 million in assets through several funds. New Leaf was formed in 2005 as the healthcare spinoff from the Sprout Group, one of the oldest U.S. venture capital funds.
Vijay Lathi, an experienced medtech investor with a focus on data convergence and guiding growth-stage companies, is joining Flosonics Medical’s board of directors. “We are thrilled to have New Leaf Venture Partners lead our Series C round and welcome Vijay Lathi to our board,” Flosonics Medical CEO Joe Eibl said. “This investment not only validates our past successes but also enables us to accelerate our plans for expansion and innovation. We are committed to leveraging this funding to further enhance the standard of care for critically ill patients with FloPatch and expand our reach into new markets.”
Flosonics Medical plans to use the Series C investment to accelerate commercial growth, expand indications for use, and continue evidence generation. The company aims to address the growing demand for wearable AI-assisted sensors to improve patient management inside and outside the hospital.
“Our investment into Flosonics is driven by the clear and significant impact their technology will have on patients in critical situations, and the quality of the team behind it. Flosonics Medical stands at the forefront of wearable ultrasound, and we look forward to contributing to their continued success,” Lathi stated on behalf of New Leaf Venture Partners.
Flosonics Medical is a Canadian medical device company engaged in the research and development of ultrasound technology. Founded in 2015, the company aims to improve patient care and the practice of medicine through technology-enabled solutions and clinical research.
New Leaf Venture Partners is a healthcare technology venture investing firm that supports both healthcare-related information technology companies and public and private biopharmaceutical companies. New Leaf currently manages more than $500 million in assets through several funds. New Leaf was formed in 2005 as the healthcare spinoff from the Sprout Group, one of the oldest U.S. venture capital funds.